Skip to main content
OpenTrials
Completed

NCT Number: NCT01292109

A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.

The study serves as a confirmation of safety, tolerance and efficacy of PICOPREP in clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bowel Cleanliness

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital, Ostrava - Poruba, Czechia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients receiving PICOPREP® for bowel evacuation prior to endoscopy or surgery

Exclusion criteria

  • Patients in which prescription of PICOPREP® is contraindicated

Treatment and study plan

sodium picosulphate

Drug

Sodium picosulphate (PICOPREP®) taken by participant prior to X-ray examination, endoscopy or surgery.

Other names: PICOPREP®

Primary outcomes

  1. Documentation of use PICOPREP in everyday practice

    Time frame: Day 0 - 2

Secondary outcomes

  1. Participant satisfaction and compliance after bowel cleansing

    Time frame: Days 0-2

  2. Participants with adverse events reported by frequency and severity

    Time frame: Days 1-2

Sponsors and collaborators

Lead sponsor

Ferring Pharmaceuticals

Industry

Registry information

Official study title

Compliance and Efficacy in the Use of PICOPREP for Bowel Cleansing

Important dates

Study start
2010
Primary completion
2011
Study completion
2012
First posted
Feb 9, 2011
Registry last updated
Feb 9, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.